Pricing Log in Create free account

Armata Pharmaceuticals, Inc. (ARMP) vs Nkarta, Inc. (NKTX)

Armata Pharmaceuticals, Inc. and Nkarta, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Nkarta, Inc. are of similar size ($112.5M and $111.5M). Nkarta, Inc. has the higher net margin (0.00% vs −3,467.0%) and the lower return on invested capital (−127.2% vs −89.6%). Across the 13 metrics below, Nkarta, Inc. leads on 7 and Armata Pharmaceuticals, Inc. on 6.

Valuation

Metric ARMP NKTX Biotechnology median
P/E n/m n/m 10.60
P/S 22.34 n/m 9.40
P/B n/m 0.53 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.42 0.66
EV/Sales 69.17 n/m 9.02
Earnings yield (157.57%) (89.71%) (32.88%)
Free cash flow yield (20.83%) (72.03%) (23.13%)

Profitability

Metric ARMP NKTX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (734.19%) 0.00% 0.00%
Net margin (3,467.04%) 0.00% 0.00%
Free cash flow margin (465.34%) 0.00% 0.00%
Return on equity 127.83% (38.76%) (51.96%)
Return on assets (225.11%) (29.86%) (46.06%)
Return on invested capital (89.61%) (127.22%) 0.00%

Growth

Metric ARMP NKTX Biotechnology median
Revenue growth (TTM) (19.29%) — 6.76%
EPS growth (last fiscal year) (440.18%) 11.88% 29.88%
Revenue growth, 5-year CAGR 42.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARMP NKTX Biotechnology median
Debt to equity (1.23) 0.00 0.00
Current ratio 0.11 7.98 4.97
Net debt to EBITDA (7.07) 2.35 1.01

Dividend

Metric ARMP NKTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ARMP NKTX Biotechnology median
Market cap 111.54m 112.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack